ESC Premium Access

Prevention of thromboembolism in COVID-19.

Congress Session

About the speaker

Associate Professor Antonio Martinez-Rubio

University Hospital of Sabadell (Univ. Autonoma of Barcelona), Sabadell (Spain)
3 presentations
0 follower

4 more presentations in this session

COVID-19 myocarditis and myocardial injury: active participant or innocent bystander?

Speaker: Professor G. Dan (Bucharest, RO)

Thumbnail

Anti-inflammatory treatment of COVID-19 patients: which drugs and which patients?

Speaker: Doctor A. Semb (Oslo, NO)

Thumbnail

Enthusiasm vs. evidence for COVID-19 pharmacotherapies: what do we know and what have we learnt? – discussion.

Thumbnail

Enthusiasm vs. evidence for COVID-19 pharmacotherapies: what do we know and what have we learnt? - Chat Moderator.

Thumbnail

Access the full session

Enthusiasm vs. evidence for COVID-19 pharmacotherapies: what do we know and what have we learnt?

Speakers: Associate Professor A. Martinez-Rubio, Professor G. Dan, Doctor A. Semb
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

The role of modifiable risk factors for the maintenance of sinus rhythm in the atrial fibrillation patient.

27 August 2021

ESC Premium Access

Ablation or amiodarone for HFrEF patients with atrial fibrillation?

27 August 2021

ESC Premium Access

When is ablation the preferred approach to treat atrial fibrillation?

27 August 2021

This platform is supported by

logo Novo Nordisk